Wiley Alexander Schell

Associate Professor in Medicine
Campus mail 303 Research Dr., Room 337 Sands Bldg., Durham, NC 27710
Phone (919) 684-2523
Email address wiley.schell@duke.edu

Education and Training

  • M.S., University of North Carolina at Chapel Hill, 1979
  • B.S., East Carolina University, 1977

Publications

Espinel-Ingroff, A., A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner, M. Pfaller, M. Rinaldi, W. Schell, and T. Walsh. “Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole..” Journal of Clinical Microbiology 43, no. 10 (October 2005): 5243–46. https://doi.org/10.1128/JCM.43.10.5243-5246.2005.

PMID
16207990
Full Text

Alexander, Barbara D., Wiley A. Schell, Jackie L. Miller, Gwynn D. Long, and John R. Perfect. “Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole..” Transplantation 80, no. 6 (September 2005): 868–71. https://doi.org/10.1097/01.tp.0000173771.47698.7b.

PMID
16210978
Full Text

Chang, Christopher Y., Wiley A. Schell, John R. Perfect, and Gregory F. Hulka. “Novel use of a swimming pool biocide in the treatment of a rare fungal mastoiditis..” The Laryngoscope 115, no. 6 (June 2005): 1065–69. https://doi.org/10.1097/01.mlg.0000163338.45700.fe.

PMID
15933522
Full Text

Steinbach, William J., Nina Singh, Jackie L. Miller, Daniel K. Benjamin, Wiley A. Schell, Joseph Heitman, and John R. Perfect. “In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients..” Antimicrobial Agents and Chemotherapy 48, no. 12 (December 2004): 4922–25. https://doi.org/10.1128/AAC.48.12.4922-4925.2004.

PMID
15561883
Full Text

Jiménez-Expósito, M. J., G. Torres, A. Baraldés, N. Benito, F. Marco, J. C. Paré, A. Moreno, et al. “Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment..” Clin Infect Dis 39, no. 7 (October 1, 2004): e70–73. https://doi.org/10.1086/424018.

PMID
15472836
Full Text

Steinbach, William J., Daniel K. Benjamin, Scott A. Trasi, Jackie L. Miller, Wiley A. Schell, Aimee K. Zaas, W Michael Foster, and John R. Perfect. “Value of an inhalational model of invasive aspergillosis..” Med Mycol 42, no. 5 (October 2004): 417–25. https://doi.org/10.1080/13693780410001712034.

PMID
15552643
Full Text

Steinbach, William J., John R. Perfect, Wiley A. Schell, Thomas J. Walsh, and Daniel K. Benjamin. “In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection..” Antimicrobial Agents and Chemotherapy 48, no. 9 (September 2004): 3217–25. https://doi.org/10.1128/AAC.48.9.3217-3225.2004.

PMID
15328076
Full Text

Miwa, Takuya, Yukinobu Takagi, Makiko Shinozaki, Cheol-Won Yun, Wiley A. Schell, John R. Perfect, Hidehiko Kumagai, and Hisanori Tamaki. “Gpr1, a putative G-protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicans..” Eukaryotic Cell 3, no. 4 (August 2004): 919–31. https://doi.org/10.1128/EC.3.4.919-931.2004.

PMID
15302825
Full Text

Odds, Frank C., Mary Motyl, Roberto Andrade, Jacques Bille, Emilia Cantón, Manuel Cuenca-Estrella, Amanda Davidson, et al. “Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species..” Journal of Clinical Microbiology 42, no. 8 (August 2004): 3475–82. https://doi.org/10.1128/JCM.42.8.3475-3482.2004.

PMID
15297486
Full Text

Steinbach, William J., Wiley A. Schell, Jill R. Blankenship, Chiatogu Onyewu, Joseph Heitman, and John R. Perfect. “In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus..” Antimicrob Agents Chemother 48, no. 5 (May 2004): 1664–69. https://doi.org/10.1128/aac.48.5.1664-1669.2004.

PMID
15105118
Full Text

Pages